FilingSEC EDGAR8-K
Tempest Therapeutics Adjourns Special Meeting to September 15
· SEC accepted
StageMeeting Adjourned
Filing content
Tempest Therapeutics adjourned its special meeting to September 15, 2026, after failing to secure sufficient votes to approve a proposal to amend its certificate of incorporation.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…